Excessive IL-17 can be detrimental for many human inflammatory and autoimmune diseases including psoriasis, arthritis, Sjogren's disease, and inflammatory bowel disease (IBD) [30–35] (Table 1). This evidence concerns the gene IL17A and inflammatory bowel disease.